ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs MXN
20.5235
0.06%
Brent Oil
79.285
3.07%
Bitcoin
94,890.81
2.68%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. SIGA Technologies Inc (SIGA)

  7. SIGA Technologies Inc (SIGA) Noticias

SIGA

SIGA Technologies (SIGA)

SIGA Technologies Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SIGA
FechaHoraFuenteTítuloSímboloCompañía
02/01/202506:30GlobeNewswire Inc.TEPOXX (tecovirimat) Approved in Japan for the Treatment of OrthopoxvirusesNASDAQ:SIGASIGA Technologies Inc
13/12/202415:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIGASIGA Technologies Inc
10/12/202415:00GlobeNewswire Inc.Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedNASDAQ:SIGASIGA Technologies Inc
08/11/202416:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SIGASIGA Technologies Inc
07/11/202415:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SIGASIGA Technologies Inc
07/11/202415:05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024NASDAQ:SIGASIGA Technologies Inc
31/10/202406:30GlobeNewswire Inc.SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
29/10/202416:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
22/10/202406:30GlobeNewswire Inc.SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal AntibodiesNASDAQ:SIGASIGA Technologies Inc
08/10/202406:30GlobeNewswire Inc.SIGA Announces Agreement to Supply TPOXX® in MoroccoNASDAQ:SIGASIGA Technologies Inc
21/08/202415:00GlobeNewswire Inc.SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®NASDAQ:SIGASIGA Technologies Inc
15/08/202406:35GlobeNewswire Inc.Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox ReleasedNASDAQ:SIGASIGA Technologies Inc
01/08/202415:05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024NASDAQ:SIGASIGA Technologies Inc
25/07/202406:30GlobeNewswire Inc.SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
19/07/202407:00GlobeNewswire Inc.SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®NASDAQ:SIGASIGA Technologies Inc
17/06/202415:05GlobeNewswire Inc.SIGA Announces Agreement to Sell TPOXX® to ASEAN Member StatesNASDAQ:SIGASIGA Technologies Inc
07/05/202415:05GlobeNewswire Inc.SIGA Reports Financial Results for Three Months Ended March 31, 2024NASDAQ:SIGASIGA Technologies Inc
01/05/202416:00GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
01/04/202415:05GlobeNewswire Inc.SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®NASDAQ:SIGASIGA Technologies Inc
25/03/202406:30GlobeNewswire Inc.SIGA Names Larry Miller General CounselNASDAQ:SIGASIGA Technologies Inc
12/03/202415:05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023NASDAQ:SIGASIGA Technologies Inc
12/03/202406:30GlobeNewswire Inc.SIGA Declares Special Cash Dividend of $0.60 Per ShareNASDAQ:SIGASIGA Technologies Inc
05/03/202406:30GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
01/02/202414:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SIGASIGA Technologies Inc
30/01/202416:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SIGASIGA Technologies Inc
22/01/202406:30GlobeNewswire Inc.SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive OfficerNASDAQ:SIGASIGA Technologies Inc
07/11/202315:05GlobeNewswire Inc.SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023NASDAQ:SIGASIGA Technologies Inc
26/10/202306:30GlobeNewswire Inc.SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial ResultsNASDAQ:SIGASIGA Technologies Inc
23/10/202307:00GlobeNewswire Inc.SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating CountriesNASDAQ:SIGASIGA Technologies Inc
06/09/202306:30GlobeNewswire Inc.SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical OfficerNASDAQ:SIGASIGA Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:SIGA

Su Consulta Reciente

CCOM
US500
US 500
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
NYSE
MRK
Merck
FX
EURUSD
Euro vs US Dollar
NYSE
MCD
McDonalds
COIN
DOGEUSD
Dogecoin
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados